Form 4: Ventyx Biosciences Chief Scientific Officer Sells Shares to Cover Tax Obligations

John Nuss, Chief Scientific Officer of Ventyx Biosciences, sold 1,651 shares of common stock on April 2, 2024, to cover tax obligations related to vesting restricted stock units.

Summary

• On April 2, 2024, John Nuss, the Chief Scientific Officer of Ventyx Biosciences, sold 1,651 shares of the company's common stock.
• The sale was executed at a weighted average price of $5.4034 per share, with individual sales occurring in the price range of $5.2704 to $5.4062.
• The transaction was a broker-assisted sale to satisfy tax withholding obligations related to the vesting of restricted stock units.
• Following the transaction, Nuss directly owns 264,998 shares of Ventyx Biosciences common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction to cover tax obligations, not indicative of a major shift in the company's prospects or insider confidence.

Industry Context

Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This sale appears to be related to tax obligations, which is a common reason for such transactions.

Stakeholder Impact

• The sale of shares by an insider could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates